Revolutions Medical Launches New Media Advertising Covering 9 Million Households

        Print
| Source: Revolutions Medical Corporation

CHARLESTON, S.C., Feb. 3, 2012 (GLOBE NEWSWIRE) -- Revolutions Medical Corporation ("Revolutions Medical" or the "Company") (OTCQB:RMCP) is pleased to announce the launch of its new media advertising relationship which will allow the company to spotlight the RevVac safety syringe over a multi-faceted media platform with access into 9 million households via cable television. The company will be running approximately three one-minute "spotlights" every two days. The "spotlights" will be scheduled in order to cover one primetime morning slot, one primetime afternoon slot, and one late night slot.

This media platform should be extremely helpful with creating additional exposure for the RevVac safety syringe as well as educating the public by providing a visual experience of construction and operation of the RevVac Safety Syringe. Full broadcast details will be posted on the Company's website when finalized.

Ron Wheet, Chief Executive Officer and Chairman of Revolutions Medical stated, "As we begin to market our RevVac safety syringe through a variety of media platforms including direct marketing, advertising in magazines and newsletters, having access to 9 million households and showing in real time the operation of our RevVac safety syringe and its features through cable television is a major step forward. Healthcare professionals and concerned patients will see firsthand how effectively our RevVac safety syringe operates and will see the benefits of reducing accidental needle stick injuries and reducing the spread of infectious diseases through contaminated needles."

The media advertising will be overseen by Acorn Management Partners who is a full service investor relations and consulting firm. "We believe this is another opportunity to expand our investor relations and consulting efforts into another networking platform and bring a value added service to Revolutions Medical. We are extremely excited about Revolutions Medical and the products that they have to offer to the healthcare industry," stated Gregory Lowe, President of Acorn Management Partners.  

About Revolutions Medical Corporation

Revolutions Medical is a safety medical device and software application company. Its products include the RevVac(TM) Safety Syringe (FDA cleared), safety blood drawing device, the RevColor(TM), RevDisplay(TM), and Rev3D(TM) software tools that are compatible with standard MRIs and standard Picture Archiving Computer Systems (PACS).

For additional information, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com

To be added to the Revolutions Medical investor email list, please email: investment@revolutionsmedical.com with RMCP in the subject line.

FORWARD-LOOKING STATEMENTS

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Revolutions Medical Corporation
Investor and Corporate Relations
Gregory S. Lowe
Acorn Management Partners
President / Partner
678-368-4013